
Ask a doctor about a prescription for Dapagliflozin Viatris 10 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Dapagliflozin Viatris 5mg film-coated tablets EFG
Dapagliflozin Viatris 10mg film-coated tablets EFG
dapagliflozin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Dapagliflozin Viatris
Dapagliflozin Viatris contains the active substance dapagliflozin. It belongs to a group of medicines called "sodium-glucose cotransporter 2 (SGLT2) inhibitors". They work by blocking the SGLT2 protein in the kidney. By blocking this protein, sugar in the blood (glucose), salt (sodium), and water are removed from the body through urine.
What Dapagliflozin Viatris is used for
Dapagliflozin Viatris is used to treat:
What is type 2 diabetes and how does Dapagliflozin Viatris help?
What is heart failure and how does Dapagliflozin Viatris help?
What is chronic kidney disease and how does Dapagliflozin Viatris help?
Do not take Dapagliflozin Viatris
Warnings and precautions
Contact a doctor or the nearest hospital immediately:
Diabetic ketoacidosis
If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital immediately and do not take this medicine.
Necrotizing fasciitis of the perineum
Consult your doctor, pharmacist, or nurse before you start taking Dapagliflozin Viatris:
If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist, or nurse before taking Dapagliflozin Viatris.
Diabetes and foot care
If you have diabetes, it is important that you regularly check your feet and follow any other foot care advice given to you by your healthcare professional.
Blood sugar in urine
Due to how Dapagliflozin Viatris works, your urine will test positive for glucose while you are taking this medicine.
Children and adolescents
Dapagliflozin Viatris can be used in children aged 10 years and older to treat type 2 diabetes. There is no data available in children under 10 years of age.
Dapagliflozin Viatris is not recommended in children and adolescents under 18 years of age to treat heart failure or to treat chronic kidney disease, as it has not been studied in these patients.
Taking Dapagliflozin Viatris with other medicines
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.
Especially tell your doctor:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should stop taking this medicine if you become pregnant, as it is not recommended during the second and third trimesters of pregnancy. Ask your doctor about the best way to control your blood sugar levels during pregnancy.
Ask your doctor if you want to breastfeed before taking this medicine. Do not take Dapagliflozin Viatris during breastfeeding. It is not known if this medicine passes into human breast milk.
Driving and using machines
Dapagliflozin Viatris has no or negligible influence on the ability to drive and use machines.
Taking this medicine with other medicines called sulfonylureas or with insulin may cause low blood sugar levels (hypoglycemia), which may cause symptoms such as shaking, sweating, and changes in vision that may affect your ability to drive or use machines.
Do not drive or use tools or machines if you feel dizzy while taking Dapagliflozin Viatris.
Dapagliflozin Viatris contains lactose
Dapagliflozin Viatris contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Dapagliflozin Viatris contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow exactly the instructions of your doctor. If you are not sure, ask your doctor, pharmacist, or nurse.
How much to take
How to take this medicine
Your doctor may prescribe Dapagliflozin Viatris with another medicine(s). Remember to take these other medicine(s) as instructed by your doctor. This will help you get the best results for your health.
Diet and exercise can help your body use blood sugar better. If you have diabetes, it is important that you follow any diet and exercise program recommended by your doctor while taking Dapagliflozin Viatris.
If you take more Dapagliflozin Viatris than you should
If you take more Dapagliflozin Viatris tablets than you should, contact your doctor or go to the hospital immediately.
Take the medicine pack with you.
If you forget to take Dapagliflozin Viatris
What you should do if you forget to take a tablet depends on how much time is left until your next dose.
If you stop taking Dapagliflozin Viatris
Do not stop taking Dapagliflozin Viatris without first talking to your doctor. If you have diabetes, your blood sugar levels may increase without this medicine.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact a doctor or the nearest hospital immediately if you get any of the following side effects:
These are the signs of angioedema:
These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):
This may happen regardless of your blood sugar levels. Your doctor will decide whether to temporarily or permanently stop your treatment with Dapagliflozin Viatris.
Stop taking Dapagliflozin Viatris and contact a doctor immediately if you notice any of these serious side effects:
These are the signs of a serious urinary tract infection:
Although not common, if you see blood in your urine, tell your doctor immediately.
Contact your doctor as soon as possible if you get any of the following side effects:
Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above signs.
Other side effects of treatment with Dapagliflozin Viatris:
Frequent
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 10,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister or carton after "EXP". The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition ofDapagliflozina Viatris
Core of the tablet: microcrystalline cellulose (E460i), lactose monohydrate (see section 2 "Dapagliflozina Viatris contains lactose"), crospovidone (E1202), magnesium stearate (E470b), sodium lauryl sulfate (see section 2 "Dapagliflozina Viatris contains sodium"), anhydrous colloidal silicon dioxide, mannitol.
Coating film: polyvinyl alcohol (E1203), titanium dioxide (E171), macrogol 6000 (E1521), talc (E553b), yellow iron oxide (E172).
Appearance of Dapagliflozina Viatris and Package Contents
Dapagliflozina Viatris 5 mg film-coated tablets are yellow, biconvex, round tablets with a diameter of approximately 7.24 mm, film-coated, with "5" engraved on one side and flat on the other.
Dapagliflozina Viatris 10 mg film-coated tablets are yellow, biconvex, rhomboid-shaped tablets with a diagonal of approximately 1.1 x 8 mm, with "10" engraved on one side and flat on the other.
Dapagliflozina Viatris 5 mg tablets are available in:
Aluminum blisters in package sizes of 14, 28, 30, or 98 film-coated tablets.
Calendar blisters of 28 or 98 film-coated tablets.
Pre-cut unit-dose blisters of 14 x 1, 28 x 1, 30 x 1, or 98 x 1 film-coated tablets.
Bottles in package sizes of 30 or 90 film-coated tablets.
Dapagliflozina Viatris 10 mg tablets are available in:
Aluminum blisters in package sizes of 14, 28, 30, or 98 film-coated tablets.
Calendar blisters of 28 or 98 film-coated tablets.
Pre-cut unit-dose blisters of 14 x 1, 28 x 1, 30 x 1, or 98 x 1 film-coated tablets.
Bottles in package sizes of 30 or 90 film-coated tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder
Viatris Limited
Damastown Industrial Park
Mulhuddart
Dublin 15
DUBLIN
Ireland
Manufacturer
Mylan Hungary Kft
Mylan Utca 1
Komárom, 2900, Hungary
Mylan Germany GmbH
Benzstrasse 1
61352 Bad Homburg
Germany
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Spain
Viatris Pharmaceuticals, S.L.
Tel: + 34 900 102 712
Date of the Last Revision of this Leaflet:July 2024
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Dapagliflozin Viatris 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.